Here’s what you should know:
1. He implanted a device called the Hydrus Microstent.
2. Dr. Endl performed the procedure at the Niagara Falls, N.Y.-based Ambulatory Surgery Center of Niagara.
3. The Hydrus Microstent received FDA approval in August.
More articles on supply chain:
Providers have power to help mistreated surgical equipment makers, study says: 6 insights
Takeda expected to win EU approval for Shire deal — Shareholder vote last hurdle
ASC supply chain tip of the day: Check your data
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
